THIS YEAR, IT'S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there's no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

GREENSBORO, N.C. — June is Men’s Health Awareness Month, and doctors are using it to push a message many men may not want to hear but need to take seriously: do not wait until something feels wrong to ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less. Ahead of Prostate Cancer Awareness Month in March, Mr Wissam Abou-Chedid, consultant ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men. Researchers now theorize that Black men may ...

The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and ...

Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...